Summit Therapeutics
SMMT
SMMT
91 hedge funds and large institutions have $37.1M invested in Summit Therapeutics in 2023 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
7% more capital invested
Capital invested by funds: $34.6M → $37.1M (+$2.51M)
1% less ownership
Funds ownership: 4.03% → 3.02% (-1%)
Holders
91
Holding in Top 10
–
Calls
$2.22M
Puts
$1.64M
Top Buyers
| 1 | +$7.53M | |
| 2 | +$2.46M | |
| 3 | +$2.29M | |
| 4 |
Millennium Management
New York
|
+$1.58M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.08M |
Top Sellers
| 1 | -$715K | |
| 2 | -$531K | |
| 3 | -$379K | |
| 4 |
KI
Kapitalo Investimentos
Sao Paulo,
Brazil
|
-$243K |
| 5 |
6CM
683 Capital Management
New York
|
-$216K |